ETX2514
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ETX2514, covering 2017-06-05 to 2018-06-14. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects [Phase 1]